Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone to reduce dexamethasone-induced neurobehavioral side effects in pediatric ALL
2017-002738-22Phase 4Completed
- Sponsor
- Princess Máxima Center for Pediatric Oncology
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute lymphoblastic leukemia (ALL) comparing Dexamethasone + hydrocortisone with Dexamethasone + placebo (2 arms). Started Jan 2018; status: completed.
02
Drugs
hydrocortisone
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2017-002738-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002738-22.